IP Library Granted Patent US 10,010,647
Granted Patent B2
US 10,010,647 · App. 15/162,890 · Granted Jul 3, 2018

Silver containing wound dressing

Inventor: David Malcolm Woods (Warwickshire, GB)
Assignee: CONVATEC TECHNOLOGIES INC.
A61L15/46A61L15/18A61L15/28A61L15/44A61L26/0023A61L26/0052A61L26/0066A61L2300/104A61L2300/404A61L2300/42Y10T428/24041Y10T428/24993Y10T442/2525Y10T442/475Y10T442/481Y10T442/655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,647
App. No.
15/162,890
Granted
Jul 3, 2018
Kind
B2
Abstract

A wound dressing having anti-microbial activity comprises a first fiber capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fiber to which silver (1) cations are bonded and a second fiber which is substantially free from silver. The wound dressing comprises from 0.01 to 5.0 percent by weight of silver (1) cations, based on the weight of fiber.

Claims (17)

1. A wound dressing having anti-microbial activity comprising a first fibre and a second fibre, the first fibre being a gel-forming fibre and having silver (I) cations bonded thereto and discoloring on exposure to light, and the second fibre being substantially free from silver, wherein the wound dressing consists of a uniform blend of the first fibre and the second fibre, the wound dressing comprises from 0.01 to 5.0 percent by weight of silver (I) cations based on a total weight of first and second fibres, and whereby a discoloration of the blend on exposure to light is lessened compared with the discoloration on exposure to light of a batch of the first fibre having a same average amount of silver (I) cations present as is present in the blend.

2. A wound dressing according to claim 1 , which comprises from 0.01 to 4.0 percent by weight of silver (I) cations based on the total weight of first and second fibres.

3. A wound dressing according to claim 1 , which comprises from 0.25 to 3.0 percent by weight of silver (I) cations based on the total weight of first and second fibres.

4. A wound dressing according to claim 1 which comprises from 1.0 to 2.0 percent by weight of silver (I) cations based on the total weight of first and second fibres.

5. A wound dressing according to claim 1 , wherein the first fibre is selected from a group consisting of a carboxymethylcellulose fibre, an alginate fibre, a chitosan fibre, a chitosan derivative fibre and an acrylic fibre.

6. A wound dressing according to claim 5 , wherein the first fibre is the carboxymethylcellulose fibre and the wound dressing contains from 1.0 to 2.0 percent by weight of silver (I) cations, based on the weight of the fibre.

7. A wound dressing according to claim 5 , wherein the first fibre is the alginate fibre and the wound dressing contains from 0.25 to 0.75 percent by weight of silver (I) cations, based on the weight of the fibre.

8. A wound dressing according to claim 5 , wherein the first fibre is the acrylic fibre which incorporates a comonomer to provide dye-sites in the fibre.

9. A wound dressing according to claim 1 , wherein the second fibre contains no silver or low levels of silver such that it discolors to a degree which is not aesthetically objectionable.

10. A wound dressing according to claim 1 , wherein the second fibre contains no silver or low levels of silver such that it does not discolor at all.

11. A wound dressing according to claim 1 , wherein a ratio of the first fibre to the second fibre is in a range of from 5 to 20% by weight of the total weight of the fibre.

12. A wound dressing according to claim 1 , wherein a ratio of the first fibre to the second fibre is in a range of from 0.5 to 25% by weight of the total weight of the fibre.

13. A wound dressing according to claim 1 , wherein the first fibre includes at least 8% by weight, based on the weight of the fibre, of silver (I) cations.

14. A wound dressing according to claim 13 , wherein the first fibre is prepared using at least a 4% silver nitrate solution.

15. A wound dressing according to claim 1 , wherein silver ions are chemically bonded to the first fibre.

16. A wound dressing according to claim 1 , wherein silver ions are introduced into the first fibre by ion-exchange.

17. A wound dressing according to claim 1 , wherein the first fibre having silver (I) cations bonded thereto is pre-exposed to light prior to blending with the second fibre.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Oct 25, 2019
From: WILMINGTON TRUST (LONDON) LIMITED
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 050831/0001 →
SECURITY AGREEMENT Recorded Nov 3, 2016
From: CONVATEC INC.; CONVATEC TECHNOLOGIES INC.; 180 MEDICAL, INC.; PRN MEDICAL SERVICES, LLC
To: WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT
Reel/Frame 040552/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2016
From: WOODS, DAVID MALCOLM
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 040141/0067 →
Priority Claims (1)
GB 0023155.5 · Sep 21, 2000 · national
Continuity (5)
Continuation 14696216 · Apr 24, 2015
Continuation 14280512 · May 16, 2014
Continuation 13767656 · Feb 14, 2013
Continuation 10311674
Related Publication 20160263274A1 · Sep 15, 2016